SCHEMBL29464495

SCHEMBL29464495

CCCOc1ccccc1-c1nc(NS(=O)(=O)c2cccc(N3CCC[C@@](C)(C(=O)O)C3)n2)ccc1C(F)(F)F

nearest known ligand 0.32

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SCN1A P35498 2/20 0.32
SCN8A Q9UQD0 2/20 0.32
SCN9A Q15858 1/20 0.32
TTR P02766 1/20 0.32
EIF2AK4 Q9P2K8 1/20 0.32
BTK Q06187 2/20 0.32
S1PR1 P21453 1/20 0.30
TAAR1 Q96RJ0 1/20 0.30
HTR1A P08908 1/20 0.30
HTR7 P34969 1/20 0.30
RAB9A P51151 1/20 0.30
DRD2 P14416 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19925737 1.00 SCN1A (0.32) SCN1ASCN8ASCN9ATTREIF2AK4
SCHEMBL19925736 1.00 SCN1A (0.32) SCN1ASCN8ASCN9ATTREIF2AK4
SCHEMBL19925190 0.94 TAAR1 (0.34) SCN1ASCN8ASCN9ATTREIF2AK4
SCHEMBL19925192 0.94 TAAR1 (0.34) SCN1ASCN8ASCN9ATTREIF2AK4
SCHEMBL19925824 0.91 SCN1A (0.32) SCN1ASCN8ASCN9ATTREIF2AK4
SCHEMBL19925823 0.91 SCN1A (0.32) SCN1ASCN8ASCN9ATTREIF2AK4
SCHEMBL19951401 0.89 SCN9A (0.33) SCN1ASCN8ASCN9ATTREIF2AK4
SCHEMBL19925421 0.89 SCN9A (0.33) SCN1ASCN8ASCN9ATTREIF2AK4
SCHEMBL19927721 0.88 SCN9A (0.32) SCN1ASCN8ASCN9AEIF2AK4BTK
SCHEMBL19951451 0.88 SCN9A (0.32) SCN1ASCN8ASCN9AEIF2AK4BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109641873-B N- (pyridin-2-yl) pyridine-sulfonamide derivatives and their use for the treatment of disease 诺华股份有限公司 2022-03-18 CN claimed
CN-109641873-B N- (pyridin-2-yl) pyridine-sulfonamide derivatives and their use for the treatment of disease 诺华股份有限公司 2022-03-18 CN disclosed